ST
STLN
Starling Oncology, Inc.
6.25
-4.29%
2026-11-02
Last 90d 1 insider buy worth $78.5K · 2 insider sales
52-week range
2.32
7.13
1-month-1.6%
3-month+20.9%
1-year+36.2%
3-year+265.5%
5-year-37.4%
vs 50-day-3.3%
vs 200-day+32.7%
Volatility80%
Beta1.61
$ vol/day$8M
ATH12.66
From ATH-50.6%
Next report2026-11-05
Nothing written about STLN yet.
Be the first — call it long or short with an entry we price for you,
or post a neutral write-up that takes no side.
Create a free account
2026AprJulOct
bought sold · bigger dot, bigger trade · follows the chart’s range
| When | People | Size | Value | Price | |
|---|---|---|---|---|---|
| 2mo | sched | 1 | $1,946,310 | 6.26 | |
| 3mo | sell | 1 | $624 | 6.47 | |
| 3mo | buy | 1 | $78,480 | 6.47 |
Next report 2026-11-05 (Thursday, after close, in 2 days) · EPS estimate -0.05. It has finished the next session higher 42% of the time, average move 15.3%.
Day-after move, last 12 reports, oldest left.
| Reported | Est. | Actual | Surprise | Gap | Day 1 | Day 5 | |
|---|---|---|---|---|---|---|---|
| 2026-08-06 | miss | -0.06 | -0.08 | -25.0% | +30.9% | +28.5% | +29.3% |
| 2026-05-07 | beat | -0.09 | -0.02 | +77.1% | -0.5% | -1.7% | -2.2% |
| 2026-03-12 | beat | -0.09 | -0.06 | +33.3% | +19.8% | +8.4% | +26.7% |
| 2025-11-13 | miss | -0.11 | -0.14 | -23.5% | +2.8% | +28.9% | +1.6% |
| 2025-08-13 | miss | -0.12 | -0.15 | -25.0% | -2.7% | -10.5% | -10.0% |
| 2024-08-13 | miss | -0.10 | -0.14 | -35.6% | -5.8% | -18.2% | -37.1% |
| 2024-05-14 | miss | -0.12 | -0.19 | -58.3% | -1.6% | -24.0% | -36.7% |
| 2024-03-26 | miss | -0.11 | -0.16 | -47.9% | +1.8% | +8.9% | -11.2% |
| 2023-11-08 | beat | -0.13 | 0.06 | +142.3% | +5.4% | +27.7% | +12.0% |
| 2023-08-08 | miss | -0.17 | -0.19 | -12.2% | -9.9% | -2.0% | -21.3% |
| 2023-03-09 | miss | -0.20 | -0.22 | -11.9% | +14.4% | -19.6% | -61.5% |
| 2022-11-09 | miss | -0.18 | -0.88 | -390.7% | +0.0% | -5.2% | -39.7% |
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+1.6%
Next 1 week
-0.0%
Next 1 month
+2.6%
Mean reversion
Deeply oversold — RSI(2) at 8
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is +0.21%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.61 +3.8% · Seasonal tilt (5y) -1.2%
$8M/day volume
80% volatility
+36% 1-year
-51% from ATH
52-week range · 82% of the way up · -12% from the high
$2.32$7.13
Not investment advice.
Continue with Google